STAT3 and melanoma: In summary, we concluded that Lj-1-60 inhibited melanoma proliferation and induced cell cycle arrest into the G2/M phase and apoptosis by targeting Fyn/Stat3 pathway (Fig. 6c), indicating Lj-1-60 is a potential therapeutic chemical that could be used in the treatment of melanoma.